You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MDGL Award Disclosure
Reed John C · SEC Form 4 · Filed Aug 18, 2026
Award
Calculated transaction value
$0
Reed John C Director
MDGL
Transaction date
Aug 15, 2026
Public filing date
Aug 18, 2026
Filing lag
Filed 3 days later
MDGL daily price context
Close on/before transaction
$507.56
Aug 14, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 1,078 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001628280-26-057751
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Madrigal Pharmaceuticals, Inc. MDGL | Award | Aug 15, 2026 | $0 |
| Madrigal Pharmaceuticals, Inc. MDGL Current | Award | Aug 15, 2026 | $0 |